L Lee, K Chang, CL Hsu, TC Chen… - International Journal of …, 2011 - ijs.sagepub.com Abstract Only 2 cases of nasopharyngeal small cell carcinoma have been reported. Another case of this rare type of nasopha- ryngeal tumor confirmed by immunopositivity for CD56, synaptophysin, and chromogranin A is described in this study. The tumor was also ... Cited by 3 - Related articles - All 3 versions
WI Wei… - Current Opinion in Otolaryngology & Head …, 2011 - journals.lww.com ... 1990. The search terms included 'recurrent nasopharyngeal carcinoma', 'recurrent nasopharynx cancer', 'radiotherapy', 'chemotherapy', 'salvage therapy', 'nasopharyngectomy' and 'combined treatment modality'. The searches ... Related articles - All 2 versions
M Johnston, S Clifford, R Bromley, M Back… - Clinical Oncology, 2011 - Elsevier Clinically acceptable plans were achieved for both IMRT and VMAT plans, although IMRT plans typically required three times the number of monitor units. The coverage of 95% of the PTV70 was between 96 and 100% of the prescribed dose for IMRT plans and 100% for all VMAT ... Cited by 1 - Related articles - All 3 versions
G Fountzilas, E Ciuleanu, M Bobos… - Annals of …, 2011 - Eur Soc Med Oncology ...Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. ... Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. ... Related articles - All 2 versions
[PDF] from sbccp.org.brWI Wei, JYW Chan, RWM Ng… - Head & neck, 2011 - sbccp.org.br ... especially for those patients who presented with an advanced stage of dis- ease.1 The outcomes for these patients have improved over the years; there are, however, still patients who developed localized persistent or recurrent carcinoma in the nasopharynx after completion of ... Cited by 1 - View as HTML